Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (NYSE:GSK)

37.70
Delayed Data
As of Dec 02
 +0.27 / +0.72%
Today’s Change
37.36
Today|||52-Week Range
45.58
-5.23%
Year-to-Date
How to Buy GlaxoSmithKline at a 15% Discount
Dec 02 / TheStreet.com - Paid Partner Content
Merck: Keytruda's Priority Review for New Cancer Indication
Nov 29 / Zacks.com - Paid Partner Content
Merck's Keytruda Gets Priority Review for Hodgkin Lymphoma
Dec 02 / Zacks.com - Paid Partner Content
Tweedy Browne Fund Investment Adviser's Semi-Annual Letter to Shareholders
Nov 28 / GuruFocus News - Paid Partner Content
Jeff Auxier Curbs Multiple Positions in 3rd Quarter
Dec 01 / GuruFocus News - Paid Partner Content
Glaxo (GSK) Files Regulatory Application for Shingrix in EU
Nov 28 / Zacks.com - Paid Partner Content
Here's the Best Dividend Stock in Big Pharma
Dec 01 / MotleyFool.com - Paid Partner Content
Glaxo Nucala Favorable in Rare Vasculitis Disease Study
Nov 24 / Zacks.com - Paid Partner Content
10 Undervalued High-Yield Dividend Stocks Worth Buying Today
Nov 30 / TheStreet.com - Paid Partner Content
3 Potentially Huge Catalysts for Ionis Pharmaceuticals, Inc. in 2017
Nov 23 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close37.43
Today’s open37.54
Day’s range37.46 - 37.85
Volume3,910,786
Average volume (3 months)3,283,380
Market cap$91.9B
Dividend yield5.54%
Data as of 12/02/2016

Growth & Valuation

Earnings growth (last year)+181.82%
Earnings growth (this year)+10.59%
Earnings growth (next 5 years)+13.26%
Revenue growth (last year)-3.66%
P/E ratio336.6
Price/Sales2.70
Price/Book12.10

Competitors

 Today’s
change
Today’s
% change
CELGCelgene-1.24-1.04%
BMYBristol-Myers Squibb+0.16+0.29%
ABBVAbbVie+0.27+0.46%
SNYSanofi+0.30+0.76%
Data as of 12/02/2016

Financials

Next reporting dateFebruary 8, 2017
EPS forecast (this quarter)$0.57
Annual revenue (last year)$36.5B
Annual profit (last year)$12.8B
Net profit margin35.20%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Andrew Philip Witty
Chief Financial Officer &
Executive Director
Simon Dingemans
Corporate headquarters
Brentford, Greater London

Forecasts


Search for Jobs